Biofrontera公布Ameluz®光动力疗法治疗四肢、颈部和躯干光化性角化病三期研究积极结果,达到主要终点

美股速递
Feb 09

Biofrontera Inc (NASDAQ: BFRI) 宣布,其用于治疗四肢、颈部和躯干光化性角化病的Ameluz®光动力疗法在三期临床研究中取得积极结果,成功达到了主要研究终点。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10